- Follicular Lymphoma2015 | First Faculty of Medicine
- Treatment of follicular lymphoma patients in 2008 +12008 | Publication without faculty affiliation
- Therapy of follicular lymphoma in 20192019 | Faculty of Medicine in Hradec Králové
- Follicular lymphoma - standard treatment options in 2007 +32008 | Publication without faculty affiliation
- Current approaches and new trends in the treatment of patients with follicular lymphomas2004 | Faculty of Medicine in Hradec Králové
- A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy2018 | Faculty of Medicine in Hradec Králové
- Idelalisib in the treatment of patients with follicular lymphoma2015 | Faculty of Medicine in Hradec Králové
- The Importance of MicroRNA Deregulation in the Molecular Pathogenesis and Histological Transformation of Follicular Lymphoma2017 | First Faculty of Medicine, Third Faculty of Medicine
- The importance of MicroRNA deregulation in the molecular pathogenesis and histological transformation of follicular lymphoma2017 | First Faculty of Medicine, Third Faculty of Medicine
- Characteristics of translocation t(14;18) (q32;q21) in patients with follicular lymphoma and methods of its detection2006 | Publication without faculty affiliation
- Characteristics of translocation t(14;18) (q32;q21) in patients with follicular lymphoma and methods of its detection +12006 | Faculty of Medicine in Hradec Králové
- Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: Is it time to change the standard strategy?2015 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine, Third Faculty of Medicine
- Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study2019 | Faculty of Medicine in Hradec Králové
- Transcriptional regulation of p21WAF1 overexpression in TGFbeta1-arrested follicular lymphomaPublication without faculty affiliation
- Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial2011 | Faculty of Medicine in Hradec Králové
- Achievement of Bcl-2/IgH negativity in peripheral blood/bone marrow is associated with better clinical outcome in patients with follicular lymphoma2007 | Publication without faculty affiliation
- Achievement of Bcl-2/IgH negativity in peripheral blood/bone marrow is associated with better clinical outcome in patients with follicular lymphoma +12007 | Faculty of Medicine in Hradec Králové
- Achievement of Bcl-2/IgH negativity in peripheral blood/bone marrow is associated with better clinical outcome in patients with follicular lymphoma2007 | First Faculty of Medicine
- Bone marrow/peripheral blood positivity of Bcl-2/IgH rearrangement in patients with follicular lymphoma before treatment has no prognostic significance2007 | Publication without faculty affiliation
- Bone marrow/peripheral blood positivity of Bcl-2/IgH rearrangement in patients with follicular lymphoma before treatment has no prognostic significance +12007 | Faculty of Medicine in Hradec Králové
- Symptoms and toxicity of rituximab maintenance relative to observation following immunochemotherapy in patients with follicular lymphoma2015 | First Faculty of Medicine
- Rituximab maintenance significantly reduces early follicular lymphoma progressions in patients treated with frontline R-CHOP2020 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
- The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database2018 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine, Third Faculty of Medicine